📰 Urea Cycle News
Page 2 - Urea Cycle News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Urea Cycle. Real-time updates on events, politics, business and more.
August 12, 2022
(2022-08-12 | NDAQ:ACER) Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
August 3, 2022
Liver cancer's rapid growth leads to a vulnerability in its energy-production and cell-building processes that may be potently exploited with a new combination-treatment strategy, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
June 24, 2022
VS-01 Reduced Plasma Metabolites Associated with Organ Failures Related to ACLF Metabolomic analysis of organ failure markers abstract selected for inclusion in the 'Best of International
May 18, 2022
At The Bridge Gallery, clay assumes various forms: a colorful slice of cake, a fox lounging on an armchair, sunflower brooches.
May 6, 2022
Relief Therapeutics Holding SA / Key word(s): Study results Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
May 6, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
April 13, 2022
Project Leverages Expertise of ZHAW School of Engineering to Develop Prototype Device Device Provides Commercial Potential as Both Standalone Product and Companion Diagnostic to Therapeutic Pipeline Versantis
April 13, 2022
Project Leverages Expertise of ZHAW School of Engineering to Develop Prototype DeviceDevice Provides Commercial Potential as Both Standalone Product and Companion Diagnostic to Therapeutic PipelineZURICH--(BUSINESS WIRE)--Versantis, a clinical-stage biotechnology company developing novel therapies for orphan and ped...
April 12, 2022
Relief Therapeutics Holding SA / Key word(s): Study results12-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeAcer Therapeutics and Relief Therape...
April 12, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.